These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7080985)

  • 21. [Study of clinical efficacy and safety of long-term cinoxacin therapy of chronic urogenital organ infection].
    Hayashi Y; Terao E; Yamasaki I
    Hinyokika Kiyo; 1987 May; 33(5):799-805. PubMed ID: 3661347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinoxacin: an overview.
    Stamey TA
    Urology; 1981 May; 17(5):492-5. PubMed ID: 7233670
    [No Abstract]   [Full Text] [Related]  

  • 23. Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.
    Sisca TS; Heel RC; Romankiewicz JA
    Drugs; 1983 Jun; 25(6):544-69. PubMed ID: 6347618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of urinary infections: clinical perspectives.
    Fontana G; Laudi M; Carlone NA; Savoia D
    Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of postoperative urinary infections in obstetrics and gynecology with cinoxacin].
    Bardi M; Manzoni A
    Clin Ter; 1988 Nov; 127(3):185-8. PubMed ID: 2976355
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of cinoxacin in infections of the urinary tract in ambulatory patients].
    Aimè G; Governa M
    Minerva Urol Nefrol; 1986; 38(2):147-50. PubMed ID: 3750156
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative clinical study of the antibacterial activity of cinoxacin and norfloxacin in urinary tract infections].
    Pennisi M; Viscusi G; Salanitri G; Cammarata E; Gazzo G
    Minerva Urol Nefrol; 1987; 39(1):51-6. PubMed ID: 3616862
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic prophylaxis of urinary tract infections in diabetic patients].
    Di Mauro M; Leonardi R; La Bella G; Iani P
    Minerva Med; 1990; 81(1-2):69-74. PubMed ID: 2314619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of cinoxacin, cotrimoxazole and pipemidic acid in recurrent infections of the lower urinary tract in long-term therapy].
    Aimè G; Governa M; Polledro P
    Minerva Urol Nefrol; 1987; 39(2):129-34. PubMed ID: 3498226
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
    Bucy JG
    J Urol; 1981 Jun; 125(6):822-4. PubMed ID: 7017171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy.
    Cox CE; Simmons JR
    South Med J; 1982 May; 75(5):549-50. PubMed ID: 7043747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections].
    Manitius A; Hebanowski M; Galiński J; Nowicki B
    Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439
    [No Abstract]   [Full Text] [Related]  

  • 33. Cinoxacin (Cinobac, Eli Lilly & Co.).
    Guay DR
    Drug Intell Clin Pharm; 1982 Dec; 16(12):916-21. PubMed ID: 6759090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of oxolinic acid in chronic urinary tract infections].
    Falkhofen R
    Ther Ggw; 1978 Jun; 117(6):926-33. PubMed ID: 663869
    [No Abstract]   [Full Text] [Related]  

  • 35. [Oxolinic acid VUFB - antibacterial effect in chronic infections of the urinary tract (author's transl)].
    Prát V; Hatala M
    Cas Lek Cesk; 1980 Dec; 119(49):1347-50. PubMed ID: 7459961
    [No Abstract]   [Full Text] [Related]  

  • 36. Cinoxacin for treatment and prevention of recurrent urinary tract infection.
    Landes RR
    Urology; 1981 May; 17(5):505-10. PubMed ID: 7015670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with oxolinic acid of urinary tract infections].
    Anzà E; Isola E; Longo F; Mellea F; Picciolo F; Potorti F; Trovato G
    Minerva Med; 1979 Jul; 70(33):2333-9. PubMed ID: 379706
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: a bacteriological and clinical assessment of a new drug-oxolinic acid.
    Drummond M
    Br J Urol; 1975 Apr; 47(2):233-4. PubMed ID: 1097025
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oxolinic acid treatment of urinary sepsis in patients with renal insufficiency].
    Biagini M; Curatola G; Gabbrielli G; Maggiore Q
    Minerva Med; 1979 Feb; 70(9):675-8. PubMed ID: 440624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection.
    Brumfitt W; Smith GW; Hamilton-Miller JM; Bax R
    J Antimicrob Chemother; 1985 Dec; 16(6):781-8. PubMed ID: 4093347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.